Oguike Ahaneku
No ORCID on file
· 2 papers in corpus
· active 2026
A non-aromatic prodrug candidate for endometriosis, designated END-102, is reported. The design eliminates aromatic rings entirely, replacing the conventional heterocyclic scaffold with a trans-4-aminocyclohexane core bearing a urea linker,…
A non-aromatic prodrug candidate for endometriosis, designated END-102, is reported. The design eliminates aromatic rings entirely, replacing the conventional heterocyclic scaffold with a trans-4-aminocyclohexane core bearing a urea linker,…